Pancreatic cancer|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Pancreatic cancer

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: Apr 27, 2017

---

• Family History Helped This Survivor Catch Pancreatic Cancer Early- About 10 percent of pancreatic cancer cases are connected to family history.  
  Celgene blog post, April 25, 2017
• Genetics of Pancreatic Cancer and Its Implications on Therapy.  
  Tatarian Talar et al. The Surgical clinics of North America 2016 Dec 96(6) 1207-1221
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.  
  Khan Mohammad Aslam Aslam et al. International journal of molecular sciences 2017 Apr 18(4)
• Molecular Genetics of Pancreatic Neoplasms.  
  Hosoda Waki et al. Surgical pathology clinics 2016 Dec (4) 685-703
• DNA testing of pancreatic cyst fluid: is it ready for prime time?  
  Singhi Aatur D et al. The lancet. Gastroenterology & hepatology 2017 Jan 2(1) 63-72
• A meta-analysis of the diagnostic value of detecting K-ras mutation in pancreatic juice as a molecular marker for pancreatic cancer.  
  Yang Jing et al. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 16(4) 605-14
• New era in precision medicine for pancreatic cancer  
  Science, March 23, 2017
• Surveillance of patients with hereditary gastrointestinal cancer syndromes.  
  Moreira Leticia et al. Best practice & research. Clinical gastroenterology 2016 Dec 30(6) 923-935
• The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.  
  Martinez-Useros Javier et al. BioMed research international 2016 20161869304
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Circulating Tumor DNA May Serve as a Prognostic Marker in Pancreatic Cancer  
  J Cavallo, ASCO Post, December 20, 2016
• Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.  
  Levin Trine et al. Familial cancer 2016 Nov
• Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.  
  Takai Erina et al. Scientific reports 2015 Dec 518425
• Genetic factors affecting patient responses to pancreatic cancer treatment.  
  Fotopoulos George et al. Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology 29(4) 466-476
• Learn About Hereditary Pancreatic Cancer  
  L Rezende, Facing Our Risk Empowered, November 1, 2016
• Risk factors for pancreatic cancer include family history & genetics  
  American Cancer Society, 2016

more